Quality of Life Impacts of Bright Light Treatment, Fluoxetine, and the Combination in Patients with Nonseasonal Major Depressive Disorder: A Randomized Clinical Trial

OBJECTIVE: Bright light therapy is increasingly recommended (alone or in combination with antidepressant medication) to treat symptoms of nonseasonal major depressive disorder (MDD). However, little is known about its impacts on quality of life (QoL), a holistic, patient-valued outcome. METHODS: Thi...

Descripció completa

Guardat en:
Dades bibliogràfiques
Publicat a:Can J Psychiatry
Autors principals: Morton, Emma, Michalak, Erin E., Levitt, Anthony, Levitan, Robert D., Cheung, Amy, Morehouse, Rachel, Ramasubbu, Rajamannar, Yatham, Lakshmi N., Tam, Edwin M., Lam, Raymond W.
Format: Artigo
Idioma:Inglês
Publicat: SAGE Publications 2020
Matèries:
Original Research
Accés en línia:https://ncbi.nlm.nih.gov/pmc/articles/PMC7958199/
https://ncbi.nlm.nih.gov/pubmed/32573396
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1177/0706743720936470
Etiquetes: Afegir etiqueta
Sense etiquetes, Sigues el primer a etiquetar aquest registre!

Ítems similars